Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1994Clinical Endocrinology

Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAart MuddeLeiden UniversityAHAlfons J.H.M. HoubenVascular MedicineAKA. C. Nieuwenhuijzen KrusemanMaastricht University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mudde et al. (1994) studied this question.

synapsesocial.com/papers/6a71541835aa2c282ce2a1e9https://doi.org/10.1111/j.1365-2265.1994.tb02571.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Morbidity in patients on l ‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH1992 · 131 citations
  2. 2Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*1990 · 377 citations
  3. 3EFFECT OF ANTITHYROID TREATMENT ON CALCIUM-PHOSPHORUS METABOLISM IN HYPERTHYROIDISM I: CHEMICAL QUANTITIES IN SERUM AND URINE1978 · 44 citations
  4. 4HYDROXYPROLINE EXCRETION IN THE URINE AND CALCIUM METABOLISM DURING LONG‐TERM TREATMENT OF THYROTOXICOSIS WITH PROPYLTHIOURACIL1971 · 16 citations
  5. 5Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?1993 · 170 citations